伊利诺伊州 的 结直肠癌 临床试验
伊利诺伊州 有 52 项针对 结直肠癌 的研究正在招募参与者。
伊利诺伊州 的城市
- Chicago34 项研究
- Peoria12 项研究
- Arlington Heights12 项研究
- Evanston10 项研究
- Cicero10 项研究
- Springfield9 项研究
- Carbondale7 项研究
- Bloomington7 项研究
- North Peoria7 项研究
- Galesburg7 项研究
- Waukegan6 项研究
- Decatur6 项研究
- Champaign6 项研究
- Danville6 项研究
- Charleston5 项研究
- Elgin4 项研究
- Naperville4 项研究
- Rockford3 项研究
- Aurora3 项研究
官方研究文本（英文）
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- The University of Chicago, Chicago
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT07454642A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- University of Chicago Medical Center /ID# 279365, Chicago
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07525206Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- Northwestern Memorial Hospital, Chicago
招募中
65 至 82 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05612347Family Communications After Genetic Testing
- OSF Saint Anthony's Health Center, Alton
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- 以及另外 46 项
招募中欢迎健康志愿者
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07143487Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- University of Illinois, Chicago
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT05673148Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- 以及另外 54 项
招募中观察性研究欢迎健康志愿者
40 至 75 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #26, Chicago
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT05176483PRE-ISPY Phase I/II Oncology Platform Program
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
- UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
- UChicago Medicine Orland Park, Orland Park
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT05868226Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Orchard Healthcare Research Inc.- Skokie, Skokie
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06324357Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare - Bloomington, Bloomington
- Illinois Cancer Specialists, Chicago
- 以及另外 10 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07222800A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- University of Chicago Medical Center /ID# 271688, Chicago
- Hope And Healing Cancer Services /ID# 271562, Hinsdale
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT06820463A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare, Peoria
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06750094Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
- City of Hope at Chicago, Zion
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07271355Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Chicago
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06218914A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare, Peoria
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06662786A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- University of Chicago, Chicago
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06004245Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月24日 · NCT05863195A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Local Institution - 0433, Chicago
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月23日 · NCT07221357Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
- University of Chicago, Chicago
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月21日 · NCT06349590A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Sih Cancer Institute, Carterville
- University of Illinois Cancer Center, Chicago
- Alexian Brothers Medical Center, Elk Grove Village
- 以及另外 2 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月15日 · NCT07284849SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
- Orchard Healthcare Research Inc., Skokie
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年9月11日 · NCT05935384A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Illinois Cancer Specialists, Arlington Heights
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月11日 · NCT04929223Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- Memorial Hospital East, Shiloh
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT06696768A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare PC, Peoria
- Springfield Clinic, Springfield
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT07549412Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Chicago
- Clinical Study Site, Elmhurst
- Clinical Study Site, O'Fallon
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT07228832Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Insight Research Institute, Chicago
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT06252649Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Lurie Children's Hospital-Chicago, Chicago
招募中1/2 期
12 Months – 30 Years · 所有性别 · 更新于 2026年8月25日 · NCT04851119A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Chicago
招募中2 期
18 至 130 岁 · 所有性别 · 更新于 2026年8月18日 · NCT06792695Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
- City of Hope at Chicago, Zion
招募中
18 岁及以上 · 所有性别 · 更新于 2026年8月12日 · NCT07125729A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Orchard Healthcare Research Inc, Skokie
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年8月5日 · NCT06330064A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Hope and Healing Cancer Services, Hinsdale
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月30日 · NCT04657068Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
- Hope and Healing Cancer Services, Hinsdale
- Orchard Healthcare Research, Skokie
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月15日 · NCT06937177A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- University of Chicago Medical Center /ID# 274742, Chicago
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月10日 · NCT07023289Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
- Northwestern University-Comprehensive Transplant Center, Chicago
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年7月10日 · NCT06698146A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Hope and Healing Cancer Services, Hinsdale
招募中4 期
18 岁及以上 · 所有性别 · 更新于 2026年7月7日 · NCT06562543A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- The University of Chicago Medical Center - Oncology, Chicago
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月2日 · NCT07169734CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, Chicago
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年6月12日 · NCT06756035A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Illinois Cancer Specialists, Arlington Heights
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年6月12日 · NCT07011576BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- OSF Healthcare Cancer Institute, Peoria
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年6月2日 · NCT06917079数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。